Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques.

Human gene therapy. Clinical development

Volumn 24, Issue 1, 2013, Pages 11-22

  Völker, Iris ^a   Bach, Patricia ^b   Coulibaly, Cheick ^b   Plesker, Roland ^b   Abel, Tobias ^b   Seifried, Janna ^b   Heidmeier, Sabine ^b   Mühlebach, Michael D ^b   Lauer, Ulrich M ^b   Buchholz, Christian J ^b  

^a PAUL EHRLICH INSTITUT   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; ANTIBODY; ANTINEOPLASTIC ANTIMETABOLITE; CYTOKINE; FLUOROURACIL; MEMBRANE COFACTOR PROTEIN; VIRUS RNA;

ANIMAL; ARTICLE; FEMALE; GENE TARGETING; GENE THERAPY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER; LIVER TUMOR; MALE; MEASLES VIRUS; METABOLISM; MOUSE; PATHOLOGY; RHESUS MONKEY; SUICIDE TRANSGENE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; ANTIGENS, CD46; ANTIMETABOLITES, ANTINEOPLASTIC; CYTOKINES; FEMALE; FLUOROURACIL; GENE KNOCK-IN TECHNIQUES; GENES, TRANSGENIC, SUICIDE; GENETIC THERAPY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MACACA MULATTA; MALE; MEASLES VIRUS; MICE; MICE, TRANSGENIC; RECEPTOR, INTERFERON ALPHA-BETA; RNA, VIRAL; TISSUE DISTRIBUTION;

EID: 84877865192     PISSN: None     EISSN: 23248645     Source Type: None    
DOI: 10.1089/humc.2012.242     Document Type: Article

References (0)